Co-Tareg 160/12.5 Mg 28 Tablets

Co-Tareg 160/12.5 Mg 28 Tablets

Description:

Co-Tareg 160/12.5 mg is a prescription antihypertensive medicine combining valsartan and hydrochlorothiazide in film-coated tablets. It is used for the treatment of high blood pressure (hypertension) in adults when blood pressure is not adequately controlled by monotherapy. Valsartan is an angiotensin II receptor blocker (ARB) that relaxes blood vessels, while hydrochlorothiazide is a thiazide diuretic that helps remove excess salt and water from the body. Together, they provide effective and sustained blood pressure reduction, helping to lower the risk of cardiovascular events such as stroke and heart attack.

Indications:

• Treatment of essential hypertension in adults.
• Management of high blood pressure in patients not adequately controlled with valsartan or hydrochlorothiazide alone.
• Helps reduce the risk of complications associated with uncontrolled hypertension, such as stroke, myocardial infarction, heart failure, and kidney damage (as part of overall cardiovascular risk management as directed by a physician).

Active Ingredients / Key Components:

• Valsartan – 160 mg per film-coated tablet.
• Hydrochlorothiazide – 12.5 mg per film-coated tablet.
• Excipients: Film-coating and tablet core excipients (full excipient list not available in the provided information; please refer to the official package leaflet for complete details).

Dosage & Administration / How to Use:

• Dosage must be determined by a physician based on the patient’s condition and response to treatment.
• Typical adult dose: one tablet of Co-Tareg 160/12.5 mg once daily, or as prescribed by your doctor.
• Swallow the tablet whole with a glass of water; do not crush or chew.
• Can be taken with or without food, but try to take it at the same time each day for best blood pressure control.
• Do not exceed the prescribed dose. If a dose is missed, take it as soon as you remember unless it is almost time for the next dose; do not double the dose.
• Regular monitoring of blood pressure, kidney function, and electrolytes (especially potassium, sodium, and magnesium) is recommended during treatment.
• Use only under medical supervision. Do not stop taking the medication abruptly without consulting your doctor, as this may worsen blood pressure control.

Clinical Benefits:

• Provides dual antihypertensive action by blocking angiotensin II receptors (valsartan) and promoting diuresis (hydrochlorothiazide) for effective blood pressure reduction.
• Helps lower the risk of cardiovascular events associated with uncontrolled hypertension, such as stroke and heart attack, when used as part of comprehensive risk management.
• Once-daily dosing supports convenient and consistent blood pressure control throughout the day.
• Combination therapy may improve blood pressure response in patients insufficiently controlled on single-agent therapy.

Warnings & Contraindications:

• Contraindicated in patients with hypersensitivity to valsartan, hydrochlorothiazide, other sulfonamide-derived drugs, or any component of the product.
• Contraindicated during pregnancy, especially in the second and third trimesters, due to risk of fetal injury and death. If pregnancy is detected, discontinue immediately and consult a doctor.
• Contraindicated in severe kidney impairment, anuria (inability to produce urine), or severe liver impairment, and in patients with cholestasis or biliary obstruction (as per prescriber’s judgment).
• Use with caution in patients with renal artery stenosis, heart failure, recent myocardial infarction, electrolyte imbalance (low sodium, low potassium, low magnesium, or high calcium), or a history of gout.
• May cause electrolyte disturbances (hypokalemia, hyponatremia, hypomagnesemia) and changes in kidney function; periodic laboratory monitoring is recommended.
• May increase sensitivity to sunlight due to hydrochlorothiazide; use sun protection and avoid excessive sun exposure.
• Use with caution in patients with diabetes, as hydrochlorothiazide may affect blood glucose levels.
• Drug interactions: Use cautiously with other antihypertensives, potassium-sparing diuretics, potassium supplements, lithium, NSAIDs, and certain other medications; always inform your doctor about all medicines you are taking.
• Consult your doctor before use if pregnant, planning pregnancy, nursing, taking other medications, or if you have medical conditions such as kidney disease, liver disease, diabetes, gout, or heart disease.
• Not intended for self-medication; use only under prescription and medical supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects may include dizziness, headache, fatigue, low blood pressure (especially when standing up), and gastrointestinal discomfort (nausea, abdominal pain).
• Hydrochlorothiazide-related effects may include increased urination, electrolyte disturbances (low potassium, low sodium, low magnesium), muscle cramps, increased blood uric acid (which may trigger gout), and changes in blood glucose or lipid levels.
• Less common but serious side effects may include severe hypotension, kidney function impairment, allergic reactions (rash, itching, swelling, difficulty breathing), severe skin reactions, or visual disturbances.
• Seek immediate medical attention if you experience signs of severe allergic reaction, marked dizziness or fainting, severe abdominal pain, difficulty breathing, swelling of face/lips/tongue, or significant reduction in urine output.
• This is not a complete list of side effects. Refer to the official package leaflet and consult your doctor or pharmacist for more information.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date stated on the packaging. Store at or below the temperature specified on the pack (refer to the original package insert for exact storage temperature if needed).

Specifications:

• Product type: Prescription antihypertensive medicine (angiotensin II receptor blocker + thiazide diuretic combination).
• Strength: 160 mg valsartan + 12.5 mg hydrochlorothiazide per film-coated tablet.
• Form: Film-coated tablets.
• Pack size: 28 tablets per pack.
• Intended use: Adult patients as prescribed by a healthcare professional for the management of high blood pressure.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.